The promise of new chemo drugs got a boost in the spring when studies found that the cancer drug Taxotere, made by Sanofi-Aventis, extended survival in prostate cases from 16 months to 18 months, the first time any chemo agent had been found to extend the life of prostate patients.

FORBES: On The Cover/Top Stories